Jonathan David Schwartz
CIK 1726398 · View on SEC EDGAR ↗
Insider
First SEC filing: April 3, 2024 · Latest: April 3, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net:
$-7,584
+ 22 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
22 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | RCKTW | S | 2,545 | $2.98 | $7,584 | 299,064 Direct | -0.84% | Disposed | -100.0% (price as of 2026-08-20) |
| Aug. 19, 2025 | RCKTW | S | 805 | $3.00 | $2,415 | 221,609 Direct | -0.36% | Disposed | -100.0% (price as of 2026-08-20) |
| Aug. 18, 2025 | RCKTW | S | 1,680 | $3.06 | $5,141 | 222,414 Direct | -0.75% | Disposed | -100.0% (price as of 2026-08-20) |
| Aug. 14, 2025 | RCKTW | S | 11,161 | $3.02 | $33,706 | 224,094 Direct | -4.74% | Disposed | -100.0% (price as of 2026-08-20) |
| May 20, 2025 | RCKTW | S | 801 | $6.45 | $5,166 | 235,255 Direct | -0.34% | Disposed | -100.0% (price as of 2026-08-20) |
| May 16, 2025 | RCKTW | S | 1,582 | $6.53 | $10,330 | 236,056 Direct | -0.67% | Disposed | -100.0% (price as of 2026-08-20) |
| Feb. 25, 2025 | RCKTW | S | 6,532 | $10.58 | $69,109 | 237,638 Direct | -2.68% | Disposed | -100.0% (price as of 2026-08-20) |
| Nov. 21, 2024 | RCKTW | S | 3,097 | $13.05 | $40,416 | 163,852 Direct | -1.86% | Disposed | -100.0% (price as of 2026-08-20) |
| Aug. 16, 2024 | RCKTW | S | 2,710 | $18.50 | $50,135 | 166,949 Direct | -1.60% | Disposed | -100.0% (price as of 2026-08-20) |
| May 17, 2024 | RCKTW | S | 2,754 | $23.35 | $64,306 | 169,659 Direct | -1.60% | Disposed | -100.0% (price as of 2026-08-20) |
| Feb. 17, 2023 | RCKTW | S | 3,557 | $19.06 | $67,796 | 94,546 Direct | -3.63% | Disposed | -100.0% (price as of 2026-08-20) |
| April 1, 2022 | RCKTW | S | 32,026 | $16.20 | $518,821 | 89,529 Direct | -26.35% | Disposed | -100.0% (price as of 2026-08-20) |
| April 1, 2022 | RCKTW | S | 12,974 | $15.86 | $205,768 | 121,555 Direct | -9.64% | Disposed | -100.0% (price as of 2026-08-20) |
| March 31, 2022 | RCKTW | S | 35,998 | $16.15 | $581,368 | 134,529 Direct | -21.11% | Disposed | -100.0% (price as of 2026-08-20) |
| March 31, 2022 | RCKTW | S | 9,002 | $15.90 | $143,132 | 170,527 Direct | -5.01% | Disposed | -100.0% (price as of 2026-08-20) |
| March 30, 2022 | RCKTW | S 10b5-1 | 34,438 | $16.56 | $570,293 | 179,529 Direct | -16.10% | Disposed | -100.0% (price as of 2026-08-20) |
| March 30, 2022 | RCKTW | S 10b5-1 | 10,562 | $15.94 | $168,358 | 213,967 Direct | -4.70% | Disposed | -100.0% (price as of 2026-08-20) |
| March 30, 2022 | RCKTW | S 10b5-1 | 34,438 | $16.56 | $570,293 | 179,529 Direct | -16.10% | Disposed | -100.0% (price as of 2026-08-20) |
| March 30, 2022 | RCKTW | S 10b5-1 | 10,562 | $15.94 | $168,358 | 213,967 Direct | -4.70% | Disposed | -100.0% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 11, 2025 | RCKTW | Stock Option (Right to Buy) | Common Stock (119,682) | $9.88 | Feb. 11, 2025 | 119,682 | Acquired |
| Feb. 14, 2023 | RCKTW | Restricted Stock Units [F1] | Common Stock (8,574) | — | — | 8,574 | Acquired |
| Feb. 14, 2023 | RCKTW | Restricted Stock Units | Common Stock (41,541) | — | — | 41,541 | Acquired |
| Feb. 14, 2023 | RCKTW | Stock Option (Right to Buy) | Common Stock (124,496) | $20.04 | Feb. 13, 2033 | 124,496 | Acquired |
| Feb. 14, 2023 | RCKTW | Restricted Stock Units | Common Stock (41,541) | — | — | 41,541 | Acquired |
| Feb. 14, 2023 | RCKTW | Stock Option (Right to Buy) | Common Stock (124,496) | $20.04 | Feb. 13, 2033 | 124,496 | Acquired |
| Aug. 12, 2022 | RCKTW | Restricted Stock Units | Common Stock (22,896) | — | — | 22,896 | Acquired |
| Feb. 14, 2022 | RCKTW | Restricted Stock Units | Common Stock (25,984) | — | — | 25,984 | Acquired |
| Feb. 14, 2022 | RCKTW | Stock Option (Right to Buy) | Common Stock (81,010) | $20.00 | Feb. 13, 2032 | 81,010 | Acquired |
| Feb. 4, 2021 | RCKTW | Stock Option (Right to Buy) | Common Stock (35,000) | $62.32 | Feb. 3, 2031 | 35,000 | Acquired |
| Feb. 1, 2021 | RCKTW | Stock Option (Right to Buy) | Common Stock (11,428) | $1.69 | April 12, 2027 | 11,428 | Disposed |
| Feb. 10, 2020 | RCKTW | Stock Option (Right to Buy) | Common Stock (213,101) | $1.21 | Feb. 8, 2026 | 213,101 | Disposed |
| Feb. 10, 2020 | RCKTW | Stock Option (Right to Buy) | Common Stock (7,000) | $23.89 | Feb. 10, 2030 | 7,000 | Acquired |
| Feb. 6, 2020 | RCKTW | Stock Option (Right to Buy) | Common Stock (75,000) | $22.72 | Feb. 6, 2030 | 75,000 | Acquired |
| Sept. 2, 2019 | RCKTW | Stock Option (Right to Buy) | Common Stock (30,000) | $10.85 | Sept. 2, 2029 | 30,000 | Acquired |
| Jan. 28, 2019 | RCKTW | Stock Option (Right to Buy) | Common Stock (75,000) | $14.56 | Jan. 28, 2029 | 75,000 | Acquired |
| March 29, 2018 | RCKTW | Stock Option (Right to Buy) | Common Stock (60,000) | $18.75 | March 29, 2028 | 60,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 12 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 3, 2024 | RCKTW | Common Stock [F1] | 172,413 | Direct |
| April 3, 2024 | RCKTW | Stock Option (Right to Buy) [F3]→ Common Stock (60,000) | 60,000 | Direct |
| April 3, 2024 | RCKTW | Stock Option (Right to Buy) [F3]→ Common Stock (75,000) | 75,000 | Direct |
| April 3, 2024 | RCKTW | Stock Option (Right to Buy) [F3]→ Common Stock (30,000) | 30,000 | Direct |
| April 3, 2024 | RCKTW | Stock Option (Right to Buy) [F3]→ Common Stock (75,000) | 75,000 | Direct |
| April 3, 2024 | RCKTW | Stock Option (Right to Buy) [F3]→ Common Stock (7,000) | 7,000 | Direct |
| April 3, 2024 | RCKTW | Stock Option (Right to Buy) [F3]→ Common Stock (35,000) | 35,000 | Direct |
| April 3, 2024 | RCKTW | Stock Option (Right to Buy) [F3]→ Common Stock (81,010) | 81,010 | Direct |
| April 3, 2024 | RCKTW | Stock Option (Right to Buy) [F3]→ Common Stock (124,496) | 124,496 | Direct |
| April 3, 2024 | RCKTW | Stock Option (Right to Buy) [F3]→ Common Stock (57,273) | 57,273 | Direct |
| Jan. 16, 2018 | RCKTW | Stock Option (Right to Buy)→ Common Stock | — | Direct |
| Jan. 16, 2018 | RCKTW | Stock Option (Right to Buy)→ Common Stock | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
RCKTW
M.D. Chief Medical and Gene Therapy Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $454,200 | — | $582,734 | $1,167,241 | $145,344 | — | $14,790 | $2,364,309 |
| 2023 | $447,433 | — | $832,482 | $1,667,492 | $196,871 | — | $13,566 | $3,157,844 |
| 2021 | $410,000 | $136,530 | — | $1,324,050 | — | — | $11,265 | $1,881,845 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.